REGENERX BIOPHARMACEUTICALS, INC.
Patent Owner
Stats
- 13 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Feb 01, 2018 most recent publication
Details
- 13 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 402 Total Citation Count
- Dec 19, 1997 Earliest Filing
- 30 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9821030 LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilizedAug 26, 11Nov 21, 17[A61K]
9504730 Method of achieving a thymosin beta 4 concentration in a human patientSep 29, 11Nov 29, 16[A61K, C07K]
9056087 Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivativesAug 29, 02Jun 16, 15[A61K, C07K]
8716215 Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said diseaseJan 13, 06May 06, 14[A61K, A61P, C07K]
8426365 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failureSep 09, 11Apr 23, 13[A61K, A61P]
8399412 Method of treating or preventing tissue deterioration, injury or damage due to periodontal disease or disease of oral mucosa, and/or downregulating NF-kappabeta or supressing NF-kappabeta-mediated actionsOct 05, 07Mar 19, 13[A61K]
8383576 LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilizedJun 19, 06Feb 26, 13[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0287,673 COMPOSITIONS AND METHODS FOR TREATING CORNEAL EPITHELIAL WOUNDAbandonedJun 15, 16Oct 06, 16[A61K]
2011/0020,449 METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN BETA 4 (TB4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVESAbandonedMay 07, 10Jan 27, 11[A61K, A61P]
2010/0278,934 METHODS AND COMPOSITIONS FOR CONSERVING AND/OR PREPARING AN ORGAN OR TISSUE FOR TRANSPLANTAbandonedAug 06, 07Nov 04, 10[A01N]
2010/0204,147 Methods For Delivering Thymosin Beta 4, Analogues, Isoforms and Other DerivativesAbandonedMar 16, 09Aug 12, 10[A61K]
2009/0214,507 METHOD OF TREATING PREVENTING, INHIBITING OR REDUCING DAMAGE TO CARDIAC TISSUEAbandonedAug 19, 05Aug 27, 09[A61K, C12Q]
2009/0169,538 Methods of Treating or Preventing Tissue Damage Caused by Increased Blood FlowAbandonedJan 17, 07Jul 02, 09[A61K]
2009/0131,313 LKKTET AND/OR LKKTNT PEPTIDE COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING TISSUE DETERIORATION, INJURY OR DAMAGEAbandonedJun 19, 06May 21, 09[A61K]
2009/0053,194 METHOD OF TREATING OR PREVENTING BIOLOGICAL OR IMMUNOLOGICAL RESPONSES TO A REACTIVE CHEMICAL OR BIOLOGICAL OR TOXIC AGENTAbandonedDec 22, 04Feb 26, 09[A61K, C12Q, A61P]
2008/0214,456 Lkktet and/or Lkktnt Peptide Compositions and MethodsAbandonedJun 19, 06Sep 04, 08[A61K]
2008/0096,817 METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN BETA 4 (Tbeta4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVESAbandonedAug 20, 07Apr 24, 08[A61K, A61P]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
